COMMUNIQUÉS West-GlobeNewswire
-
Bone Therapeutics SA: Strengthens Board of Directors
03/07/2017 - 07:00 -
Bone Therapeutics SA : Renforce son Conseil d'administration
03/07/2017 - 07:00 -
New Study with Abiomed's Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
30/06/2017 - 14:17 -
Targovax ASA: Approval and publication of prospectus; the subsequent offering
30/06/2017 - 13:42 -
Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering
30/06/2017 - 09:48 -
Integrums bokslutskommuniké 1 maj 2016 - 30 april 2017
30/06/2017 - 08:32 -
VALNEVA annonce le succès de son Assemblée Générale et la nomination de deux nouveaux membres à son Conseil de Surveillance
30/06/2017 - 07:00 -
VALNEVA Announces Successful Outcome of its AGM and the Appointment of two new Supervisory Board Members
30/06/2017 - 07:00 -
Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung
30/06/2017 - 07:00 -
Résultats de l'Assemblée Générale Mixte d'AB Science du 28 juin 2017
29/06/2017 - 18:44 -
Aino Health AB (publ): Aino Health co-founds the corporate healthcare company Maresan Oy
29/06/2017 - 17:15 -
Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury
29/06/2017 - 14:00 -
iTeos Therapeutics SA: Appoints Mohamed Ragab, M.D. as Vice President, Corporate Development
29/06/2017 - 14:00 -
ObsEva Announces Presentations Related to its Assisted Reproductive Technology (ART) and Pre-term labor (PTL) Development Programs at ESHRE 2017 Annual Meeting
29/06/2017 - 13:00 -
TiGenix opens US headquarters in Cambridge, MA
29/06/2017 - 11:30 -
TiGenix ouvre à Cambridge (Massachusetts) son siège central aux États-Unis
29/06/2017 - 11:30 -
Bio-on presents "The Matter". Bioplastic technology now open source for researchers around the world
29/06/2017 - 08:30 -
Bio-on présente «The Matter». La technologie du bioplastique est désormais « Open source » au service des chercheurs du monde entier.
29/06/2017 - 08:30 -
Novartis receives EU approval for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)
29/06/2017 - 07:15
Pages